Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Quetiapine fumarate
Drug ID BADD_D01889
Description Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder.[L8546] Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivity to other drugs, such as [Clozapine] and [Olanzapine].[A2189]
Indications and Usage Quetiapine is used in the symptomatic treatment of schizophrenia. In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546] Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson's disease.[A185438,A185447,T685]
Marketing Status approved
ATC Code N05AH04
DrugBank ID DB01224
KEGG ID D00458
MeSH ID D000069348
PubChem ID 441261
TTD Drug ID D0H7KF
NDC Product Code 80425-0184; 82009-097; 16364-147; 65096-0106; 76072-1009; 16571-722; 16729-097; 29300-149; 29300-150; 33342-099; 47335-902; 47335-903; 50090-3983; 50742-635; 51407-073; 63629-4841; 65862-495; 67296-1243; 68071-2158; 68071-2712; 68071-2728; 68180-448; 68180-449; 68180-450; 68180-615; 0054-0223; 0054-0229; 70518-1018; 70518-3190; 70518-3656; 72189-366; 72189-477; 0615-8471; 0615-8474; 0781-5343; 82009-098; 0904-6639; 15894-0005; 16364-150; 48087-0068; 65015-699; 65862-494; 69037-0064; 73005-0003; 16729-095; 29300-148; 29300-151; 31722-767; 31722-768; 46708-135; 50090-3342; 50090-5884; 50268-630; 50268-632; 50742-638; 51407-071; 55700-941; 63629-4964; 63739-690; 65862-489; 67877-242; 68071-3463; 68788-7950; 68788-8348; 68788-8444; 71335-9697; 72789-266; 0781-5344; 82009-095; 0904-6638; 0904-6641; 0904-6803; 12666-0008; 59765-150; 65862-490; 65862-491; 66577-033; 68069-0006; 16571-718; 16571-721; 16714-379; 29300-147; 33342-104; 46708-139; 47335-906; 50742-637; 51407-070; 51407-074; 55154-7881; 55700-903; 63739-677; 67296-1394; 67877-246; 67877-250; 68071-1892; 68180-445; 68180-616; 0054-0222; 68788-8390; 70518-2424; 70518-2466; 71205-788; 71610-128; 0615-8473; 67877-245; 68001-511; 68001-512; 0054-0220; 68788-8065; 70518-0767; 70518-2102; 70518-2175; 71335-2176; 0781-5348; 0904-6642; 11712-700; 12780-4930; 16364-146; 49711-1506; 59765-149; 62331-039; 16571-809; 16729-132; 31722-764; 33342-105; 34908-636; 46708-136; 46708-138; 47335-907; 55154-3359; 67877-247; 68180-612; 68180-614; 70518-0645; 70518-2502; 70518-2523; 70518-2726; 70518-2752; 70518-2901; 71335-0926; 71335-1519; 71335-9627; 82009-096; 0904-6802; 16364-145; 50923-0483; 53296-0061; 59765-148; 68554-0024; 68554-0089; 16571-720; 16714-375; 31722-766; 33342-100; 50090-3333; 50268-634; 51407-075; 55111-249; 55111-606; 63629-4776; 68001-515; 68180-447; 70518-2522; 70518-3609; 71335-1462; 71610-127; 71610-141; 72189-340; 72189-446; 72189-465; 0781-5342; 0904-6801; 16364-149; 53747-101; 65862-493; 16571-717; 16571-719; 16714-380; 29300-152; 31722-769; 33342-103; 34908-637; 34908-639; 43353-004; 46708-137; 51407-066; 55111-186; 55111-188; 55111-190; 55154-8092; 61919-084; 63187-452; 63739-665; 67296-1336; 68180-613; 0054-0230; 70518-0638; 70518-0974; 70518-1918; 70518-2454; 70518-3429; 71335-0772; 0781-5345; 0781-5346; 16364-148; 59765-147; 65372-1114; 16714-378; 31722-765; 43353-011; 43353-957; 50090-6337; 50268-633; 50268-635; 50742-639; 67877-249; 68180-446; 0054-0221; 70518-0975; 70518-2672; 71205-031; 71335-1562; 71335-9623; 0781-5347; 80425-0186; 0904-6643; 59765-145; 59765-146; 16714-376; 34908-638; 43353-008; 46708-134; 51407-067; 51407-077; 63187-269; 65862-492; 68001-513; 68788-7813; 68788-7960; 70518-0594; 70518-2701; 70518-3761; 71335-1353; 71335-1709; 0615-8470; 0615-8472; 0904-6805; 14799-1102; 15308-0320; 52932-0735; 65862-262; 66651-910; 16729-109; 33342-101; 43353-955; 50268-631; 50742-636; 51407-068; 51407-069; 51407-076; 55111-189; 63187-219; 67296-1582; 67877-248; 68001-514; 70518-1034; 70518-3581; 71335-1362; 71335-2157; 71610-136; 71610-140; 0904-6640; 0904-6804; 16436-0061; 55111-053; 59285-024; 77777-114; 16714-377; 16729-096; 47335-904; 47335-905; 50090-5473; 55111-169; 55154-7894
UNII 2S3PL1B6UJ
Synonyms Quetiapine Fumarate | Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt) | Seroquel | ICI 204,636 | ICI-204636 | ICI204636 | ICI 204636 | Quetiapine | 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
Chemical Information
Molecular Formula C46H54N6O8S2
CAS Registry Number 111974-72-2
SMILES C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4= CC=CC=C42.C(=CC(=O)O)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tongue oedema23.04.01.009; 10.01.05.008; 07.14.02.007--Not Available
Tooth abscess11.01.04.003; 07.09.01.003--Not Available
Tremor17.01.06.002--
Urinary incontinence17.05.01.008; 20.02.02.010--
Urinary retention20.02.02.011--
Urinary tract disorder20.08.01.001--Not Available
Urinary tract infection20.08.02.001; 11.01.14.004--
Vaginal discharge21.08.02.002--
Vaginal haemorrhage24.07.03.005; 21.08.01.001--
Vaginal infection21.14.02.002; 11.01.10.002--
Vasodilatation24.03.02.003; 23.06.05.006--Not Available
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.10.013--Not Available
Vomiting07.01.07.003--
Vulvovaginal candidiasis21.14.02.003; 11.03.03.005--Not Available
Vulvovaginitis21.14.02.005; 11.01.10.003--Not Available
Water intoxication19.07.03.004; 14.05.06.004; 05.03.03.003--Not Available
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Balance disorder08.01.03.081; 17.02.02.007--Not Available
Electrocardiogram T wave abnormal13.14.05.009--
Deep vein thrombosis24.01.02.003--Not Available
Musculoskeletal stiffness15.03.05.027--Not Available
Inappropriate antidiuretic hormone secretion05.03.03.001; 14.05.07.001--Not Available
Affect lability19.04.01.001--Not Available
Dysphemia19.19.03.005; 17.02.08.010--Not Available
Haemorrhage24.07.01.002--Not Available
Nuchal rigidity17.05.02.006; 15.05.04.005--Not Available
Restless legs syndrome17.02.07.008; 15.05.03.012--Not Available
The 8th Page    First    Pre   8 9    Next   Last    Total 9 Pages